8月19日，昭衍新药(06127)盘中下跌5.13%，报25.54港元，成交额8150.29万港元。该股此前连续两日大幅上涨，8月17日涨6.22%、8月18日涨6.30%，短期累计涨幅较大。
消息面上，CXO板块今日整体承压，同业药明生物跌2.06%、药明康德跌1.17%、药明合联跌3.01%、英矽智能跌3.23%。此外，公司原副董事长左从林8月13日披露拟减持不超过352.45万股，叠加年内大股东合计套现规模较大，减持压力对市场情绪形成持续压制。公司将于8月28日召开董事会审议中期业绩，市场或存在业绩公布前的获利了结行为。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.